Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clonidine 25microgram tablets
0407042F0AAAAAA
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 60,215 |
|
Clonidine 100microgram tablets
0205020E0AAACAC
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 18,870 |
|
Clonidine 50micrograms/5ml oral solution sugar free
0407042F0AAAZAZ
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 3,940 |
|
Catapres 100microgram tablets
0205020E0BBAAAC
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 736 |
|
Clonidine 300micrograms/24hours transdermal patches
0205020E0AAAHAH
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 185 |
|
Clonidine 100micrograms/24hours transdermal patches
0205020E0AAAFAF
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 129 |
|
Clonidine 200micrograms/24hours transdermal patches
0205020E0AAAGAG
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 86 |
|
Clonidine 50micrograms/5ml oral liquid
0407042F0AAAFAF
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 71 |
|
Clonidine 150micrograms/1ml solution for injection ampoules
0205020E0AAABAB
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 67 |
|
Dixarit 25microgram tablets
0407042F0BBAAAA
|
Dixarit | Clonidine hydrochloride | Central Nervous System | 13 |
|
Catapres TTS 1 patches
0205020E0BBAEAF
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 12 |
|
Clonidine 100micrograms/5ml oral liquid
0407042F0AAALAL
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 8 |
|
Catapres 150micrograms/1ml solution for injection ampoules
0205020E0BBADAB
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 1 |
|
Catapres TTS 2 patches
0205020E0BBAFAG
|
Catapres | Clonidine hydrochloride | Cardiovascular System | 1 |
|
Clonidine 125micrograms/5ml oral liquid
0407042F0AAARAR
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 250micrograms/5ml oral solution
0407042F0AAAVAV
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 25micrograms/5ml oral liquid
0407042F0AAAGAG
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Clonidine 3.75micrograms/5ml oral suspension
0407042F0AAAYAY
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 1 |
|
Catapres 300microgram tablets
0205020E0BBABAD
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Catapres PL Perlongets 250microgram capsules
0205020E0BBACAA
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Catapres TTS 3 patches
0205020E0BBAGAH
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Clonidine 100micrograms/5ml oral solution sugar free
0407042F0AABBBB
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 10micrograms/5ml oral liquid
0407042F0AAAMAM
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 12.5micrograms/5ml oral liquid
0407042F0AAANAN
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 15micrograms/5ml oral liquid
0407042F0AAAKAK
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.